0
     

Report Added
Report already added
Nucleic Vaccine Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Nucleic Vaccine Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

A nucleic vaccine is to directly introduce an exogenous gene (DNA or RNA) encoding an antigen protein into an animal body cell, and synthesize the antigen protein through an expression system of a host cell to induce the host to produce an immune response to the antigen protein to achieve prevention And the purpose of treating the disease.

This report contains market size and forecasts of Nucleic Vaccine in India, including the following market information:
India Nucleic Vaccine Market Revenue, 2015-2020, 2021-2026, ($ millions)
India Nucleic Vaccine Market Consumption, 2015-2020, 2021-2026, (K Units)
India Nucleic Vaccine Production Capacity, 2015-2020, 2021-2026, (K Units)
Top Five Competitors in India Nucleic Vaccine Market 2019 (%)
The global Nucleic Vaccine market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Nucleic Vaccine market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nucleic Vaccine manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Nucleic Vaccine production and consumption in India
Total Market by Segment:
India Nucleic Vaccine Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Units)
India Nucleic Vaccine Market Segment Percentages, By Type, 2019 (%)
Preventive Nucleic Vaccine
Therapeutic Nucleic Vaccine

India Nucleic Vaccine Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Units)
India Nucleic Vaccine Market Segment Percentages, By Application, 2019 (%)
Hospital
Clinic
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Nucleic Vaccine Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)
Total Nucleic Vaccine Market Competitors Revenues Share in India, by Players 2019 (%)
Total India Nucleic Vaccine Market Competitors Sales, by Players 2015-2020 (Estimated), (K Units)
Total India Nucleic Vaccine Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
Moderna
CureVac
Inovio
Sanofi
GSK
CNBG
Hualan Bio
Zhifei Shengwu
Liaoning Chengda
BioKangtai
CanSinoBIO
Walvax Biotechnology
Fosun Pharma
1 Introduction to Research & Analysis Reports
1.1 Nucleic Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 India Nucleic Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

India Nucleic Vaccine Overall Market Size
2.1 India Nucleic Vaccine Market Size: 2020 VS 2026
2.2 India Nucleic Vaccine Revenue, Prospects & Forecasts: 2015-2026
2.3 India Nucleic Vaccine Sales (Consumption): 2015-2026

3 Company Landscape
3.1 Top Nucleic Vaccine Players in India (including Foreign and Local Companies)
3.2 Top India Nucleic Vaccine Companies Ranked by Revenue
3.3 India Nucleic Vaccine Revenue by Companies (including Foreign and Local Companies)
3.4 India Nucleic Vaccine Sales by Companies (including Foreign and Local Companies)
3.5 India Nucleic Vaccine Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Nucleic Vaccine Companies in India, by Revenue in 2019
3.7 India Manufacturers Nucleic Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nucleic Vaccine Players in India
3.8.1 List of India Tier 1 Nucleic Vaccine Companies
3.8.2 List of India Tier 2 and Tier 3 Nucleic Vaccine Companies

4 Market Sights by Product
4.1 Overview
4.1.1 By Type - India Nucleic Vaccine Market Size Markets, 2020 & 2026
4.1.2 Preventive Nucleic Vaccine
4.1.3 Therapeutic Nucleic Vaccine
4.2 By Type - India Nucleic Vaccine Revenue & Forecasts
4.2.1 By Type - India Nucleic Vaccine Revenue, 2015-2020
4.2.2 By Type - India Nucleic Vaccine Revenue, 2021-2026
4.2.3 By Type - India Nucleic Vaccine Revenue Market Share, 2015-2026
4.3 By Type - India Nucleic Vaccine Sales & Forecasts
4.3.1 By Type - India Nucleic Vaccine Sales, 2015-2020
4.3.2 By Type - India Nucleic Vaccine Sales, 2021-2026
4.3.3 By Type - India Nucleic Vaccine Sales Market Share, 2015-2026
4.4 By Type - India Nucleic Vaccine Price (Manufacturers Selling Prices), 2015-2026
5 Market Sights by Application
5.1 Overview
5.1.1 By Application - India Nucleic Vaccine Market Size, 2020 & 2026
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - India Nucleic Vaccine Revenue & Forecasts
5.2.1 By Application - India Nucleic Vaccine Revenue, 2015-2020
5.2.2 By Application - India Nucleic Vaccine Revenue, 2021-2026
5.2.3 By Application - India Nucleic Vaccine Revenue Market Share, 2015-2026
5.3 By Application - India Nucleic Vaccine Sales & Forecasts
5.3.1 By Application - India Nucleic Vaccine Sales, 2015-2020
5.3.2 By Application - India Nucleic Vaccine Sales, 2021-2026
5.3.3 By Application - India Nucleic Vaccine Sales Market Share, 2015-2026
5.4 By Application - India Nucleic Vaccine Price (Manufacturers Selling Prices), 2015-2026
6 Manufacturers & Brands Profiles
6.1 Moderna
6.1.1 Moderna Corporate Summary
6.1.2 Moderna Business Overview
6.1.3 Moderna Nucleic Vaccine Major Product Offerings
6.1.4 Moderna Sales and Revenue in India (2015-2020)
6.1.5 Moderna Key News
6.2 CureVac
6.2.1 CureVac Corporate Summary
6.2.2 CureVac Business Overview
6.2.3 CureVac Nucleic Vaccine Major Product Offerings
6.2.4 CureVac Sales and Revenue in India (2015-2020)
6.2.5 CureVac Key News
6.3 Inovio
6.3.1 Inovio Corporate Summary
6.3.2 Inovio Business Overview
6.3.3 Inovio Nucleic Vaccine Major Product Offerings
6.3.4 Inovio Sales and Revenue in India (2015-2020)
6.3.5 Inovio Key News
6.4 Sanofi
6.4.1 Sanofi Corporate Summary
6.4.2 Sanofi Business Overview
6.4.3 Sanofi Nucleic Vaccine Major Product Offerings
6.4.4 Sanofi Sales and Revenue in India (2015-2020)
6.4.5 Sanofi Key News
6.5 GSK
6.5.1 GSK Corporate Summary
6.5.2 GSK Business Overview
6.5.3 GSK Nucleic Vaccine Major Product Offerings
6.5.4 GSK Sales and Revenue in India (2015-2020)
6.5.5 GSK Key News
6.6 CNBG
6.6.1 CNBG Corporate Summary
6.6.2 CNBG Business Overview
6.6.3 CNBG Nucleic Vaccine Major Product Offerings
6.6.4 CNBG Sales and Revenue in India (2015-2020)
6.6.5 CNBG Key News
6.7 Hualan Bio
6.6.1 Hualan Bio Corporate Summary
6.6.2 Hualan Bio Business Overview
6.6.3 Hualan Bio Nucleic Vaccine Major Product Offerings
6.4.4 Hualan Bio Sales and Revenue in India (2015-2020)
6.7.5 Hualan Bio Key News
6.8 Zhifei Shengwu
6.8.1 Zhifei Shengwu Corporate Summary
6.8.2 Zhifei Shengwu Business Overview
6.8.3 Zhifei Shengwu Nucleic Vaccine Major Product Offerings
6.8.4 Zhifei Shengwu Sales and Revenue in India (2015-2020)
6.8.5 Zhifei Shengwu Key News
6.9 Liaoning Chengda
6.9.1 Liaoning Chengda Corporate Summary
6.9.2 Liaoning Chengda Business Overview
6.9.3 Liaoning Chengda Nucleic Vaccine Major Product Offerings
6.9.4 Liaoning Chengda Sales and Revenue in India (2015-2020)
6.9.5 Liaoning Chengda Key News
6.10 BioKangtai
6.10.1 BioKangtai Corporate Summary
6.10.2 BioKangtai Business Overview
6.10.3 BioKangtai Nucleic Vaccine Major Product Offerings
6.10.4 BioKangtai Sales and Revenue in India (2015-2020)
6.10.5 BioKangtai Key News
6.11 CanSinoBIO
6.11.1 CanSinoBIO Corporate Summary
6.11.2 CanSinoBIO Nucleic Vaccine Business Overview
6.11.3 CanSinoBIO Nucleic Vaccine Major Product Offerings
6.11.4 CanSinoBIO Sales and Revenue in India (2015-2020)
6.11.5 CanSinoBIO Key News
6.12 Walvax Biotechnology
6.12.1 Walvax Biotechnology Corporate Summary
6.12.2 Walvax Biotechnology Nucleic Vaccine Business Overview
6.12.3 Walvax Biotechnology Nucleic Vaccine Major Product Offerings
6.12.4 Walvax Biotechnology Sales and Revenue in India (2015-2020)
6.12.5 Walvax Biotechnology Key News
6.13 Fosun Pharma
6.13.1 Fosun Pharma Corporate Summary
6.13.2 Fosun Pharma Nucleic Vaccine Business Overview
6.13.3 Fosun Pharma Nucleic Vaccine Major Product Offerings
6.13.4 Fosun Pharma Sales and Revenue in India (2015-2020)
6.13.5 Fosun Pharma Key News

7 Nucleic Vaccine Production Capacity, Export and Import Analysis
7.1 Nucleic Vaccine Production Capacity and Value in India, Situation Analysis and Prediction, 2015-2026
7.1.1 India Nucleic Vaccine Production Capacity, 2015-2026
7.1.2 India Nucleic Vaccine Production 2015-2026
7.1.3 India Nucleic Vaccine Production Value 2015-2026
7.2 Key Local Nucleic Vaccine Manufacturers in India
7.2.1 India Key Local Nucleic Vaccine Manufacturers Production Capacity
7.2.2 India Key Local Nucleic Vaccine Manufacturers Production
7.2.3 India Key Local Nucleic Vaccine Manufacturers Production Value
7.2.4 The Proportion of Nucleic Vaccine Production Sold in India and Sold Other Than India by Manufacturers
7.3 Nucleic Vaccine Export and Import in India
7.3.1 India Nucleic Vaccine Export Market
7.3.2 India Nucleic Vaccine Source of Imports

8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 PESTLE Analysis for India Nucleic Vaccine Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 Nucleic Vaccine Supply Chain Analysis
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Nucleic Vaccine Distributors and Sales Agents in India

10 Conclusion

11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 DisclaimerList of Tables
Table 1. Key Players of Nucleic Vaccine in India
Table 2. Top Players in India, Ranking by Revenue (2019)
Table 3. India Nucleic Vaccine Revenue by Companies, (US$, Mn), 2015-2020
Table 4. India Nucleic Vaccine Revenue Share by Companies, 2015-2020
Table 5. India Nucleic Vaccine Sales by Companies, (K Units), 2015-2020
Table 6. India Nucleic Vaccine Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Nucleic Vaccine Price (2015-2020) (US$/Unit)
Table 8. India Manufacturers Nucleic Vaccine Product Type
Table 9. List of India Tier 1 Nucleic Vaccine Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of India Tier 2 and Tier 3 Nucleic Vaccine Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Nucleic Vaccine Revenue in India (US$, Mn), 2015-2020
Table 12. By Type - Nucleic Vaccine Revenue in India (US$, Mn), 2021-2026
Table 13. By Type - Nucleic Vaccine Sales in India (K Units), 2015-2020
Table 14. By Type - Nucleic Vaccine Sales in India (K Units), 2021-2026
Table 15. By Application - Nucleic Vaccine Revenue in India, (US$, Mn), 2015-2020
Table 16. By Application - Nucleic Vaccine Revenue in India, (US$, Mn), 2021-2026
Table 17. By Application - Nucleic Vaccine Sales in India, (K Units), 2015-2020
Table 18. By Application - Nucleic Vaccine Sales in India, (K Units), 2021-2026
Table 19. Moderna Corporate Summary
Table 20. Moderna Nucleic Vaccine Product Offerings
Table 21. Moderna Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 22. CureVac Corporate Summary
Table 23. CureVac Nucleic Vaccine Product Offerings
Table 24. CureVac Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 25. Inovio Corporate Summary
Table 26. Inovio Nucleic Vaccine Product Offerings
Table 27. Inovio Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 28. Sanofi Corporate Summary
Table 29. Sanofi Nucleic Vaccine Product Offerings
Table 30. Sanofi Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 31. GSK Corporate Summary
Table 32. GSK Nucleic Vaccine Product Offerings
Table 33. GSK Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 34. CNBG Corporate Summary
Table 35. CNBG Nucleic Vaccine Product Offerings
Table 36. CNBG Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 37. Hualan Bio Corporate Summary
Table 38. Hualan Bio Nucleic Vaccine Product Offerings
Table 39. Hualan Bio Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 40. Zhifei Shengwu Corporate Summary
Table 41. Zhifei Shengwu Nucleic Vaccine Product Offerings
Table 42. Zhifei Shengwu Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 43. Liaoning Chengda Corporate Summary
Table 44. Liaoning Chengda Nucleic Vaccine Product Offerings
Table 45. Liaoning Chengda Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 46. BioKangtai Corporate Summary
Table 47. BioKangtai Nucleic Vaccine Product Offerings
Table 48. BioKangtai Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 49. CanSinoBIO Corporate Summary
Table 50. CanSinoBIO Nucleic Vaccine Product Offerings
Table 51. CanSinoBIO Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 52. Walvax Biotechnology Corporate Summary
Table 53. Walvax Biotechnology Nucleic Vaccine Product Offerings
Table 54. Walvax Biotechnology Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 55. Fosun Pharma Corporate Summary
Table 56. Fosun Pharma Nucleic Vaccine Product Offerings
Table 57. Fosun Pharma Nucleic Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2015-2020)
Table 58. Nucleic Vaccine Production Capacity (K Units) of Local Manufacturers in India, 2015-2020
Table 59. Nucleic Vaccine Production (K Units) of Local Manufacturers in India, 2015-2020
Table 60. India Nucleic Vaccine Production Market Share of Local Manufacturers, 2015-2020
Table 61. Nucleic Vaccine Production Value (US$, Mn) of Local Manufacturers in India, 2015-2020
Table 62. India Nucleic Vaccine Production Value Market Share of Local Manufacturers, 2015-2020
Table 63. The Percentage of Nucleic Vaccine Production Sold in India and Sold Other Than India by Manufacturers
Table 64. The Percentage of Nucleic Vaccine Production Sold in India and Sold Other Than India by Manufacturers
Table 65. India Nucleic Vaccine Sales (Consumption), Production, Export and Import, 2015-2020
Table 66. Raw Materials and Suppliers
Table 67. Nucleic Vaccine Downstream Clients in India
Table 68. Nucleic Vaccine Distributors and Sales Agents in India
List of Figures
Figure 1. Nucleic Vaccine Segment by Type
Figure 2. Nucleic Vaccine Segment by Application
Figure 3. India Nucleic Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Nucleic Vaccine Market Size in India, (US$, Mn) & (K Units): 2020 VS 2026
Figure 6. India Nucleic Vaccine Revenue, 2015-2026 (US$, Mn)
Figure 7. Nucleic Vaccine Sales in India: 2015-2026 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nucleic Vaccine Revenue in 2019
Figure 9. By Type - India Nucleic Vaccine Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - India Nucleic Vaccine Market Share, 2015-2020
Figure 11. By Type - India Nucleic Vaccine Market Share, 2020-2026
Figure 12. By Type - India Nucleic Vaccine Price (US$/Unit), 2015-2026
Figure 13. By Application - Nucleic Vaccine Revenue in India (US$, Mn), 2020 & 2026
Figure 14. By Application - India Nucleic Vaccine Market Share, 2015-2020
Figure 15. By Application - India Nucleic Vaccine Market Share, 2020-2026
Figure 16. By Application -India Nucleic Vaccine Price (US$/Unit), 2015-2026
Figure 17. India Nucleic Vaccine Production Capacity (K Units), 2015-2026
Figure 18. India Nucleic Vaccine Actual Output (K Units), 2015-2026
Figure 19. India Nucleic Vaccine Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of India Nucleic Vaccine Export Destination, 2019
Figure 21. The Source of Imports of India Nucleic Vaccine, 2019
Figure 22. PEST Analysis for India Nucleic Vaccine Market in 2020
Figure 23. Nucleic Vaccine Market Opportunities & Trends in India
Figure 24. Nucleic Vaccine Market Drivers in India
Figure 25. Nucleic Vaccine Market Restraints in India
Figure 26. Nucleic Vaccine Industry Value Chain

Report Title: Nucleic Vaccine Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW